Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-2-9
pubmed:abstractText
Survivin is a member of the inhibitors of apoptosis family and is overexpressed in different types of malignancies. Cytotoxic T cells recognizing survivin epitopes can be elicited in vitro and by vaccination in patients with leukemia, breast cancer, and melanoma. We did this study to investigate whether survivin-specific CD8+ T cells occur in patients with multiple myeloma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1053-60
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17289902-Aged, pubmed-meshheading:17289902-Antigens, CD45, pubmed-meshheading:17289902-Apoptosis, pubmed-meshheading:17289902-CD8-Positive T-Lymphocytes, pubmed-meshheading:17289902-Cell Line, Tumor, pubmed-meshheading:17289902-Epitopes, pubmed-meshheading:17289902-Female, pubmed-meshheading:17289902-Gene Expression Regulation, Neoplastic, pubmed-meshheading:17289902-Humans, pubmed-meshheading:17289902-Inhibitor of Apoptosis Proteins, pubmed-meshheading:17289902-Interferon-gamma, pubmed-meshheading:17289902-Male, pubmed-meshheading:17289902-Microtubule-Associated Proteins, pubmed-meshheading:17289902-Middle Aged, pubmed-meshheading:17289902-Multiple Myeloma, pubmed-meshheading:17289902-Neoplasm Proteins, pubmed-meshheading:17289902-Receptors, CCR7, pubmed-meshheading:17289902-Receptors, Chemokine
pubmed:year
2007
pubmed:articleTitle
CD8+ T cells reactive to survivin antigen in patients with multiple myeloma.
pubmed:affiliation
Department of Hematology and Oncology, Institute of Pathology, University of Regensburg, Regensburg, Germany. matthias.grube@klinik.uni-regensburg.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't